Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

367 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Treatment of NASH with ursodeoxycholic acid: cons.
Liechti F, Dufour JF. Liechti F, et al. Among authors: dufour jf. Clin Res Hepatol Gastroenterol. 2012 Sep;36 Suppl 1:S46-52. doi: 10.1016/S2210-7401(12)70021-9. Clin Res Hepatol Gastroenterol. 2012. PMID: 23141894
[Treatment of nonalcoholic steatohepatitis].
Bürgi AC, Dufour JF. Bürgi AC, et al. Among authors: dufour jf. Rev Prat. 2012 Dec;62(10):1425-7. Rev Prat. 2012. PMID: 23424927 Review. French.
Time to Abandon NASH?
Dufour JF. Dufour JF. Hepatology. 2016 Jan;63(1):9-10. doi: 10.1002/hep.28276. Epub 2015 Nov 30. Hepatology. 2016. PMID: 26452651 No abstract available.
Treatment of Non-Alcoholic Fatty Liver Disease.
Scherer A, Dufour JF. Scherer A, et al. Among authors: dufour jf. Dig Dis. 2016;34 Suppl 1:27-31. doi: 10.1159/000447278. Epub 2016 Aug 22. Dig Dis. 2016. PMID: 27548081 Free article. Review.
Treatment of non-alcoholic steatohepatitis patients with vitamin D: a double-blinded, randomized, placebo-controlled pilot study.
Geier A, Eichinger M, Stirnimann G, Semela D, Tay F, Seifert B, Tschopp O, Bantel H, Jahn D, Marques Maggio E, Saleh L, Bischoff-Ferrari HA, Müllhaupt B, Dufour JF. Geier A, et al. Among authors: dufour jf. Scand J Gastroenterol. 2018 Sep;53(9):1114-1120. doi: 10.1080/00365521.2018.1501091. Epub 2018 Sep 29. Scand J Gastroenterol. 2018. PMID: 30270688 Clinical Trial.
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial.
Younossi ZM, Ratziu V, Loomba R, Rinella M, Anstee QM, Goodman Z, Bedossa P, Geier A, Beckebaum S, Newsome PN, Sheridan D, Sheikh MY, Trotter J, Knapple W, Lawitz E, Abdelmalek MF, Kowdley KV, Montano-Loza AJ, Boursier J, Mathurin P, Bugianesi E, Mazzella G, Olveira A, Cortez-Pinto H, Graupera I, Orr D, Gluud LL, Dufour JF, Shapiro D, Campagna J, Zaru L, MacConell L, Shringarpure R, Harrison S, Sanyal AJ; REGENERATE Study Investigators. Younossi ZM, et al. Among authors: dufour jf. Lancet. 2019 Dec 14;394(10215):2184-2196. doi: 10.1016/S0140-6736(19)33041-7. Epub 2019 Dec 5. Lancet. 2019. PMID: 31813633 Free article. Clinical Trial.
367 results